Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells

Olivier Meurette1, Spyros Stylianou, Rebecca Rock

  • 1Wellcome Trust Centre for Cell Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom. olivier.meurette@manchester.ac.uk

Cancer Research
|June 4, 2009
PubMed

Insights

Notch pathway activation in breast cancer promotes cell survival by activating Akt, which prevents apoptosis. Inhibiting Notch signaling reduces Akt activity, increasing cancer cell sensitivity to apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Aberrant Notch pathway activation is common in breast cancer, maintaining tumor cell survival.
  • Notch signaling prevents apoptosis, but the underlying mechanism is not fully understood.

Purpose of the Study:

  • To elucidate the mechanism by which Notch signaling suppresses apoptosis in breast epithelial cells.
  • To investigate the role of Akt signaling in Notch-mediated cytoprotection.

Main Methods:

  • Utilized the MCF10A nontransformed breast epithelial cell line and human breast cancer cells.
  • Investigated Notch signaling, Akt activation, and apoptosis.
  • Examined the role of ASK1 and c-Jun NH(2)-terminal kinase (JNK) in the pathway.

Main Results:

  • Notch signaling induces an autocrine loop activating Akt in breast epithelial cells.
  • Akt activation is essential for Notch-mediated apoptosis protection in MCF10A cells.
  • Inhibition of Notch signaling in breast cancer cells decreased Akt activity and increased apoptosis sensitivity.
  • Akt-mediated inhibition of ASK1 prevented JNK-mediated p53 activation, conferring resistance to DNA damage-induced apoptosis.

Conclusions:

  • Notch signaling promotes breast cancer cell survival through an Akt-dependent pathway.
  • Targeting the Notch-Akt axis may represent a therapeutic strategy for breast cancer by enhancing apoptosis.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...